Aldeyra The(ALDX)
Biotechnology
Rare Disease / Orphan Drug
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership changeShares owned | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-06-05 | Brady Todd C President and CEO | Purchase | +250,000 | +6.16%4,310,768 | $1.67 | $418,450 | View SEC filing | |
| 2026-03-20 | DOUGLAS RICHARD Director | Purchase | +70,000 | +56.00%195,000 | $1.40 | $98,000 | View SEC filing | |
| 2026-03-19 | Alfieri Michael Principal Financial Officer | Purchase | +5,000 | +200.00%7,500 | $1.42 | $7,100 | View SEC filing | |
| 2025-08-15 | Alfieri Michael Principal Financial Officer | Purchase | +2,500 | +100.00%2,500 | $5.30 | $13,250 | View SEC filing | |
| 2025-08-13 | Machatha Stephen Chief Development Officer | Sale | -22,073 | -9.05%221,799 | $5.15 | $113,713 | View SEC filing | |
| 2025-04-07 | EDELMAN JOSEPH 10% Owner | Sale | -3,400,000 | -36.65%5,875,851 | $1.42 | $4,828,000 | View SEC filing | |
| 2024-10-21 | Miller-Rich Nancy Director | Purchase | +922 | +100.00%922 | $11.33 | $10,447 | View SEC filing | |
| 2024-08-14 | Machatha Stephen Chief Development Officer | Sale | -16,041 | -6.35%236,771 | $4.74 | $75,975 | View SEC filing | |
| 2024-08-14 | Greenberg Bruce See Remarks | Sale | -10,834 | -7.90%126,382 | $4.74 | $51,313 | View SEC filing | |
| 2024-04-17 | Machatha Stephen Chief Development Officer | Sale | -11,537 | -4.36%252,812 | $3.16 | $36,503 | View SEC filing | |
| 2024-04-17 | Greenberg Bruce See Remarks | Sale | -13,201 | -9.21%130,154 | $3.41 | $44,968 | View SEC filing | |
| 2024-04-08 | EDELMAN JOSEPH 10% Owner | Purchase | +177,993 | +1.96%9,275,851 | $4.68 | $833,867 | View SEC filing | |
| 2024-04-03 | EDELMAN JOSEPH 10% Owner | Purchase | +504,272 | +5.87%9,097,858 | $3.84 | $1,934,505 | View SEC filing | |
| 2024-03-12 | Greenberg Bruce See Remarks | Sale | -13,201 | -9.86%120,699 | $3.41 | $44,968 | View SEC filing | |
| 2024-03-12 | Machatha Stephen Chief Development Officer | Sale | -29,768 | -10.89%243,706 | $3.31 | $98,605 | View SEC filing | |
| 2024-03-12 | Brady Todd C President and CEO | Sale | -183,238 | -11.07%1,471,298 | $3.17 | $580,760 | View SEC filing | |
| 2023-10-18 | EDELMAN JOSEPH 10% Owner | Sale | -2,756,499 | -24.29%8,593,586 | $1.62 | $4,453,308 | View SEC filing | |
| 2022-08-11 | EDELMAN JOSEPH 10% Owner | Purchase | +115,000 | +1.02%11,350,085 | $7.55 | $867,750 | View SEC filing | |
| 2022-08-10 | EDELMAN JOSEPH 10% Owner | Purchase | +97,000 | +0.87%11,235,085 | $7.24 | $702,280 | View SEC filing | |
| 2022-08-09 | EDELMAN JOSEPH 10% Owner | Purchase | +141,000 | +1.28%11,138,085 | $6.95 | $979,950 | View SEC filing | |
| 2022-08-08 | EDELMAN JOSEPH 10% Owner | Purchase | +95,100 | +0.87%10,997,085 | $6.17 | $586,767 | View SEC filing | |
| 2022-08-05 | EDELMAN JOSEPH 10% Owner | Purchase | +100,000 | +0.93%10,901,985 | $5.84 | $584,000 | View SEC filing | |
| 2022-08-04 | EDELMAN JOSEPH 10% Owner | Purchase | +412,406 | +3.97%10,801,985 | $5.59 | $2,305,350 | View SEC filing | |
| 2022-08-03 | EDELMAN JOSEPH 10% Owner | Purchase | +144,185 | +1.41%10,389,579 | $5.05 | $728,134 | View SEC filing | |
| 2022-08-02 | EDELMAN JOSEPH 10% Owner | Purchase | +222,123 | +2.22%10,245,394 | $5.03 | $1,117,279 | View SEC filing |
1-25 of 70